White Paper

Perception of Value of Breakthrough Designation in Saudi Arabia

Read time: 7 mins

The Saudi Food and Drug Authority (SFDA) is the regulatory authority in Saudi Arabia responsible for granting national marketing authorisation for all pharmaceutical products and medical devices

To continue reading and gain complete access,
please submit your details below.

Date Icon

February 2026

Share this article

Related White Papers

August 2024

Rare Disease Funding: A Spotlight on Saudi Arabia

November 2025

The Localization Imperative: Navigating the New Localization Requirements in Saudi Arabia

April 2023

ATMPs: Critical Success Drivers for the Achievement of Premium Pricing in Saudi Arabia